The New York Post e-Edition

Impact drug

A Food and Drug Administration panel unanimously agreed that Biogen and Eisai have proven the efficacy of their Alzheimer’s drug Leqembi, clearing the way for agency approval.

BUSINESS

en-us

2023-06-10T07:00:00.0000000Z

2023-06-10T07:00:00.0000000Z

https://nypost.pressreader.com/article/282123525911857

New York Post